Finding a fatty liver is only the surface. Has it already caused liver fibrosis? How close is it to cirrhosis or liver cancer? These are the questions that matter - and a 2025 study published in the International Journal of Hepatology found that about 44 percent of people with metabolic dysfunction-associated fatty liver disease progress from simple fatty liver to metabolic dysfunction-associated steatohepatitis within seven years, after which fibrosis, cirrhosis and even liver cancer can follow.

Case Overview: Hidden Damage Behind an Asymptomatic Fatty Liver

A 42-year-old male executive with frequent business engagements and years of regular drinking had elevated blood pressure, blood lipids, blood glucose, uric acid, inflammation markers and body weight, but no significant physical discomfort. A baseline abdominal ultrasound showed a fatty liver.

Fatty liver plus long-term drinking means a double burden on the liver. Research shows that heavy drinkers have a 4.6-fold higher risk of liver fibrosis than non-drinkers, and for those with both fatty liver and heavy drinking, liver-related mortality rises to 9.8-fold [1].

A Multimodal Evaluation Plan

After the checkup, a joint report review across several specialties found that blood tests had already shown multiple metabolic problems. Based on a risk profile of age, long-term alcohol use, abdominal obesity, multiple metabolic abnormalities and abnormal liver enzymes, the team designed a multimodal in-depth liver evaluation.

Quantifying the Damage: MRE and Multimodal Imaging

Liver MR elastography (MRE) and multimodal imaging quantified the damage across fat load, liver-cell swelling and inflammation, and fibrosis stiffness. MRE showed a mean liver stiffness of 5.3 kPa. Based on thresholds from the RSNA journal Radiology: below 2.5 kPa is normal; 2.5-3.0 kPa is normal or inflammation; 3.0-3.5 kPa suggests stage 1-2 fibrosis; 3.5-4.0 kPa stage 2-3; 4.0-5.0 kPa stage 3-4; and above 5.0 kPa stage 4 fibrosis or cirrhosis. Fat quantification showed moderate hepatic fat infiltration (10-25 percent) with no obvious iron overload, and T1 mapping gave a cT1 of 1,100 ms, suggesting metabolic steatohepatitis or fibrosis.

Internationally, MRE generates two images in about 32 seconds - one recording the liver's vibration wave, the other mapping stiffness by colour. Blue indicates healthy soft liver; red and yellow indicate worsening fibrosis - catching early fibrosis that a conventional ultrasound cannot see.

Multidisciplinary Care and Follow-Up

The team coordinated with a gastroenterology professor at a tertiary hospital in Shanghai and held a multidisciplinary consultation combining imaging, metabolic and cardiovascular data. The conclusion covered metabolic dysfunction-associated steatohepatitis (MASH), early fibrosis, type 2 diabetes, obesity and mixed hyperlipidemia, and a functional-medicine team designed an integrated diet, exercise, nutrition and inflammation-management plan. Follow-up is ongoing, with a planned clinical review three months later.

For people with fatty liver or long-term drinking, hidden liver damage is worth attention: MRE quantifies that damage numerically and makes liver health visible.

This article is general health information based on a case-sharing example and is not medical advice. Any post-processing data analysis report is based on the images from that examination and the information provided, is for clinical reference only, and the final imaging diagnostic report prevails. Please follow your treating physician's instructions for any examination or treatment decision, and consult a qualified clinician before changing medication or follow-up plans.

References

  • [1] Cho SH, et al. Metabolic dysfunction-associated fatty liver disease and heavy alcohol consumption increase mortality: a nationwide study. Hepatol Int. 2024;18(4):1168-1177.
  • Moura Cunha G, et al. Interpretation, Reporting, and Clinical Applications of Liver MR Elastography. Radiology. 2024;310(3):e231220.